Bevacizumab (AVASTIN) and age-related macular degeneration. Lower cost does not justify taking risks (Q86309123)
Jump to navigation
Jump to search
scientific article published on 01 September 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab (AVASTIN) and age-related macular degeneration. Lower cost does not justify taking risks |
scientific article published on 01 September 2015 |
Statements
Bevacizumab (AVASTIN) and age-related macular degeneration. Lower cost does not justify taking risks (English)
1 September 2015